Full Year Results FY21
Filed with ASX · · 4 pages · English
In the deck
Story so far
Earlier from Nova Eye Medical
- FY21 Investor presentation
- FY21 Trading Update
- First Patient enrolled in MAGIC Clinical Trial
- 2RT Post LEAD Review Shows Improved Treatment Benefits
- Clinical trial to Assess Efficacy and Safety of i Track
Later from Nova Eye Medical
- Aquisition of Glaucoma Patents
- US Government Stimulus Loan Forgiven
- EYE AGM Presentation
- Glaucoma Sales Update
- Half year results discussion
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical